| Patent | Date |
|---|
Normalizing Measured Drug Concentrations In Oral Fluids And Testing For Potential Non-compliance With Drug Treatment Regimen
App 20180045744 - Mcintire; Gregory L. ; et al. | 2018-02-15 |
Methods Of Monitoring Adherence To Quetiapine Therapy
App 20170356923 - McIntire; Gregory L. ; et al. | 2017-12-14 |
Methods Of Monitoring For Adherence To Aripiprazole Therapy
App 20170299574 - McIntire; Gregory L. ; et al. | 2017-10-19 |
Methods Of Monitoring For Adherence To Brexpiprazole (rexulti.rtm.) Therapy
App 20170276692 - McIntire; Gregory L. ; et al. | 2017-09-28 |
Methods Of Monitoring Adherence To Lurasidone Therapy
App 20170192025 - Enders; Jeffrey ; et al. | 2017-07-06 |
Methods of monitoring adherence to lurasidone therapy
Grant 9,606,132 - Enders , et al. March 28, 2 | 2017-03-28 |
Methods Of Monitoring Adherence To Haloperidol Therapy
App 20170029866 - Strickland; Erin ; et al. | 2017-02-02 |
Methods Of Normalizing Measured Drug Concentrations In Urine Using Patient Specific Data And Testing For Potential Non-compliance With A Chronic Drug Treatment Regimen
App 20160300038 - McIntire; Gregory L. ; et al. | 2016-10-13 |
Enzymatic Hydrolysis Of Glucuronide Conjugated Drugs In The Presence Of Water Miscible Organic Media
App 20160076075 - McIntire; Gregory L. ; et al. | 2016-03-17 |
Methods Of Normalizing The Ratio Of Measured Parent And Metabolite Drug Concentrations In Fluids And Testing For Non-compliance
App 20160041146 - McIntire; Gregory L. ; et al. | 2016-02-11 |
Methods Of Monitoring Adherence To Quetiapine Therapy
App 20160041192 - McIntire; Gregory L. ; et al. | 2016-02-11 |
Methods Of Monitoring For Adherence To Aripiprazole Therapy
App 20160003800 - McIntire; Gregory L. ; et al. | 2016-01-07 |
Methods of monitoring for adherence to aripiprazole therapy
Grant 9,170,264 - McIntire , et al. October 27, 2 | 2015-10-27 |
Methods Of Monitoring Adherence To Lurasidone Therapy
App 20150168431 - Enders; Jeffrey ; et al. | 2015-06-18 |
Methods Of Monitoring For Adherence To Aripiprazole Therapy
App 20140284467 - McIntire; Gregory L. | 2014-09-25 |
Polymorphs of brimonidine pamoate
Grant 8,637,514 - Wang , et al. January 28, 2 | 2014-01-28 |
Polymorphs of brimonidine pamoate
Grant 8,637,515 - Wang , et al. January 28, 2 | 2014-01-28 |
Polymorphs of Brimonidine Pamoate
App 20130203760 - Wang; Hongna ; et al. | 2013-08-08 |
Polymorphs of Brimonidine Pamoate
App 20130203761 - Wang; Hongna ; et al. | 2013-08-08 |
Polymorphs of brimonidine pamoate
Grant 8,420,648 - Wang , et al. April 16, 2 | 2013-04-16 |
System for selecting and purchasing assets and maintaining an investment portfolio
Grant 8,165,948 - O'Shaughnessy , et al. April 24, 2 | 2012-04-24 |
Polymorphs of Brimonidine Pamoate
App 20120015951 - Wang; Hongna ; et al. | 2012-01-19 |
Polymorphs of brimonidine pamoate
Grant 8,034,813 - Wang , et al. October 11, 2 | 2011-10-11 |
Complexes Comprising alpha2-Adrenergic Receptor Agonists and Methods of Providing Neuroprotection or Treating or Inhibiting Progression of Glaucoma
App 20110183946 - McIntire; Gregory L. ; et al. | 2011-07-28 |
System For Selecting And Purchasing Assets And Maintaining An Investment Portfolio
App 20100325062 - O'Shaughnessy; James P. ; et al. | 2010-12-23 |
Polymorphs of Brimonidine Pamoate
App 20100125077 - Wang; Hongna ; et al. | 2010-05-20 |
Method For Prolonging Activity Of Autodegradable Enzymes And Compositions Thereof
App 20100104551 - Jani; Dharmendra M. ; et al. | 2010-04-29 |
System for selecting and purchasing assets and maintaining an investment portfolio
Grant 7,707,093 - O'Shaughnessy , et al. April 27, 2 | 2010-04-27 |
Complexes Comprising alpha2-Adrenergic Receptor Agonists and Compositions
App 20080293728 - McIntire; Gregory L. ; et al. | 2008-11-27 |
Non-Surgical Method for Preventing or Reducing the Rate of the Progression of Non-Proliferative Diabetic Retinopathy and the Treatment of Other Ocular Conditions
App 20080008698 - Bartels; Stephen P. ; et al. | 2008-01-10 |
Non-Surgical Method for Preventing or Reducing the Rate of the Progression of Non-Proliferative Diabetic Retinopathy and the Treatment of Other Ocular Conditions
App 20070141043 - Bartels; Stephen P. ; et al. | 2007-06-21 |
Method for prolonging activity of autodegradable enzymes and compositions thereof
App 20070134231 - Jani; Dharmendra M. ; et al. | 2007-06-14 |
Non-Surgical Method for Preventing or Reducing the Rate of the Progression of Non-Proliferative Diabetic Retinopathy and the Treatment of Other Ocular Conditions
App 20070128182 - Bartels; Stephen P. ; et al. | 2007-06-07 |
System For Selecting And Purchasing Assets And Maintaining An Investment Portfolio
App 20070130043 - O'Shaughnessy; James P. ; et al. | 2007-06-07 |
System and method for selecting and purchasing stocks via a global computer network
Grant 7,177,831 - O'Shaughnessy , et al. February 13, 2 | 2007-02-13 |
Non-surgical method for preventing or reducing the rate of the progression of non-proliferative diabetic retinopathy and the treatment of other ocular conditions
App 20060257391 - Bartels; Stephen P. ; et al. | 2006-11-16 |
Apparatus and methods for radiotherapy
App 20060199991 - Lewis; Dewi M. ; et al. | 2006-09-07 |
Apparatus and methods for radiotherapy
Grant 7,011,619 - Lewis , et al. March 14, 2 | 2006-03-14 |
Enhanced radiation therapy
App 20040047804 - Wolf, Gerald L. ; et al. | 2004-03-11 |
Microprecipitation of nanoparticulate pharmaceutical agents using surface active material derived from similar pharmaceutical agents
Grant 5,716,642 - Bagchi , et al. February 10, 1 | 1998-02-10 |
Microprecipitation of micro-nanoparticulate pharmaceutical agents
Grant 5,662,883 - Bagchi , et al. September 2, 1 | 1997-09-02 |
Sulfated nonionic block copolymer surfactants as stabilizer coatings for nanoparticle compositions
Grant 5,569,448 - Wong , et al. October 29, 1 | 1996-10-29 |
Microprecipitation of nanoparticulate pharmaceutical agents
Grant 5,560,932 - Bagchi , et al. October 1, 1 | 1996-10-01 |
X-ray contrast compositions useful in medical imaging
Grant 5,451,393 - Liversidge , et al. September 19, 1 | 1995-09-19 |
Water insoluble non-magnetic manganese particles as magnetic resonance contract enhancement agents
Grant 5,401,492 - Kellar , et al. March 28, 1 | 1995-03-28 |
X-ray contrast compositions containing an organic crystalline X-ray contrast agent in combination with pharmaceutically acceptable clays
Grant 5,360,604 - Ruddy , et al. November 1, 1 | 1994-11-01 |
Use of purified surface modifiers to prevent particle aggregation during sterilization
Grant 5,352,459 - Hollister , et al. October 4, 1 | 1994-10-04 |
Iodinated wetting agents
Grant 5,346,688 - Bacon , et al. September 13, 1 | 1994-09-13 |
X-ray contrast compositions useful in medical imaging
Grant 5,318,767 - Liversidge , et al. June 7, 1 | 1994-06-07 |
| 